Tesla stock slips 3.4% as Morgan Stanley cuts rating to Equal Weight

Highlights

Tesla dropped 3.4% as Morgan Stanley downgraded the stock to “Equal Weight”, pointing to valuation concerns.
The firm raised its price target from $410 to $425 but sees limited upside in the near term.
Technical signals suggest Tesla may remain range-bound between $420 and $470 without a new catalyst.

Technically, Tesla is trading in a volatile, sideways range between $420 and $470. The next support lies near $430, which marks a previous consolidation zone from late November. A breakdown below that could open room for a decline toward $400–$410, where the 100-day moving average sits. On the upside, $470 remains the key resistance to watch, just shy of the 52-week high at $488.54.

Volume has picked up slightly, with intraday volumes approaching 70 million shares — suggesting elevated activity, possibly from institutional repositioning following recent analyst updates. The Relative Strength Index (RSI) has slipped below 50, indicating weakening bullish momentum. MACD signals have also started to flatten, suggesting limited upside pressure in the immediate term.

Tesla stock price dynamics (October 2025 - December 2025). Source: TradingView

Overall, Tesla’s current price action suggests a lack of conviction from buyers. The technical structure leans bearish short-term unless a catalyst drives the stock decisively above the $470 mark. Recent volume spikes hint at institutional repositioning, but without follow-through, upward moves are fading quickly. Momentum indicators remain neutral to weak, reinforcing the view of limited upside in the near term.

Morgan Stanley downgrade reflects strategic pause, not structural weakness

The key driver of Tesla’s latest price action was a downgrade by Morgan Stanley, which shifted its rating from “Overweight” to “Equal Weight” while slightly raising the price target from $410 to $425. While this revision doesn’t reflect a loss of confidence in Tesla’s long-term vision, it signals hesitation about the current entry point and near-term risk-reward balance.

According to Morgan Stanley, Tesla’s stock price has run ahead of fundamentals. The firm believes Tesla is fairly valued in the mid-$400s given the current trajectory of electric vehicle (EV) sales, intensifying competition, and a slower-than-expected adoption curve for autonomous driving technology.

Interestingly, the bank still maintains a highly bullish long-term outlook. Their base-case model values Optimus — Tesla’s humanoid robot project — at roughly $60 per share. They also continue to see value in Tesla’s ability to monetize its software stack, especially through Full Self-Driving (FSD) and potential robotaxi services. However, these bets are considered high-risk and longer-term in nature.

Range-bound until new catalysts materialize

In the base case, Tesla finds support around $430 and fluctuates between $420 and $470 amid mixed macro signals and ongoing wait-and-see sentiment from institutions. No major breakout occurs until new data on deliveries, AI progress, or macro drivers emerge. This scenario assumes a neutral tone from the Federal Reserve and steady consumer demand, allowing Tesla to consolidate without significant downside.

In the bull case, a surprise upside from Q4 delivery numbers, credible news on FSD deployment, or positive macro tailwinds such as a dovish Fed pivot could push Tesla above $470 toward $500–$520 — retesting 52-week highs. Continued progress in AI development and broader tech sector strength would further reinforce this breakout potential.

Dutch regulators may soon approve Tesla’s Full Self-Driving (FSD) system for use in Europe, with the Netherlands’ RDW seen as a key gateway. Such approval could expand Tesla’s software revenue and support its transition to a mobility-focused tech platform.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.